1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Conference Proceedings: not found

      Abstract P6-17-02: Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-low expressing breast cancer: Updated results of a large phase 1 study

      proceedings-article
      , , , , , , , , , , , , , , ,
      Abstracts: 2018 San Antonio Breast Cancer Symposium; December 4-8, 2018; San Antonio, Texas

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Conference
          February 15 2019
          February 15 2019
          : P6-17-02
          Article
          10.1158/1538-7445.SABCS18-P6-17-02
          83904b6e-884f-4e9f-b2e2-52187e3c004e
          © 2019
          Abstracts: 2018 San Antonio Breast Cancer Symposium; December 4-8, 2018; San Antonio, Texas
          History

          Comments

          Comment on this article